Closed-loop insulin delivery for glycemic control in noncritical care

New England Journal of Medicine

Volumn 379, Issue 6, 2018, Pages 547-556

  Bally, Lia ^a,b,c   Thabit, Hood ^c,f,g   Hartnell, Sara ^e   Andereggen, Eveline ^a   Ruan, Yue ^c   Wilinska, Malgorzata E ^b,c,d   Evans, Mark L ^c,e   Wertli, Maria M ^a   Coll, Anthony P ^c,e   Stettler, Christoph ^a   Hovorka, Roman ^c,d  

^a and Metabolism   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL PRACTICE; CLOSED LOOP INSULIN DELIVERY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFORMED CONSENT; INJECTION SITE CONTUSION; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; SWITZERLAND; TERTIARY CARE CENTER; UNITED KINGDOM; ADVERSE DEVICE EFFECT; AGED; ANALYSIS; ARTIFICIAL PANCREAS; BLOOD; CLINICAL TRIAL; HOSPITALIZATION; INSULIN INFUSION; MIDDLE AGED; MULTICENTER STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL;

EID: 85051415796     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1805233     Document Type: Article

References (29)

1. International Diabetes Federation. IDF diabetes atlas. 8th ed. 2017 (http://www.diabetesatlas.org/).
2. National Diabetes Inpatient Audit (NaDIA) 2017. NHS Digital. 2018 (https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-inpatient-audit/national-diabetes-inpatient-audit-nadia-2017).
3. Bach LA, Ekinci EI, Engler D, et al. The high burden of inpatient diabetes mellitus: the Melbourne Public Hospitals Diabetes Inpatient Audit. Med J Aust 2014; 201:334-8.
4. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care 1998;21:246-9.
5. American Diabetes Association. Dia-betes care in the hospital: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41:Suppl 1:S144-S151.
6. Umpierrez GE, Hellman R, Korytkow-ski MT, et al. Management of hyperglyce-mia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:16-38.
7. Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total paren-teral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care 2010; 33: 739-41.
8. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet 2009; 373:1798-807.
9. Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular ap-proach to understanding and treatment. Diabetes Metab Res Rev 2014; 30: 96-102.
10. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undi-agnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82.
11. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011;34:256-61.
12. Murad MH, Coburn JA, Coto-Yglesias F, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012;97:49-58.
13. Nirantharakumar K, Marshall T, Ken-nedy A, Narendran P, Hemming K, Cole-man JJ. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized. Diabet Med 2012; 29(12): e445-e448.
14. Swanson CM, Potter DJ, Kongable GL, Cook CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract 2011;17:853-61.
15. Draznin B, Gilden J, Golden SH, et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013; 36: 1807-14.
16. Bally L, Thabit H, Hovorka R. Closed-loop for type 1 diabetes-an introduction and appraisal for the generalist. BMC Med 2017;15:14.
17. Bekiari E, Kitsios K, Thabit H, et al. Artificial pancreas treatment for outpa-tients with type 1 diabetes: systematic review and meta-analysis. BMJ 2018; 361: k1310.
18. Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015; 373: 2129-40.
19. Leelarathna L, English SW, Thabit H, et al. Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial. Crit Care 2013; 17: R159.
20. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 2009; 32: 1425-7.
21. Thabit H, Hartnell S, Allen JM, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endo-crinol 2017;5:117-24.
22. Evans S, Day S, Royston P. MINIM: a program for randomising patients to treatments groups in clinical trials by the methods of minimisation (http://www-users.york.ac.uk/~mb55/guide/minimins.doc).
23. Christensen MB, Gotfredsen A, Nør-gaard K. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev 2017; 33(5).
24. Rushakoff RJ, Sullivan MM, MacMas-ter HW, et al. Association between a virtual glucose management service and glycemic control in hospitalized adult patients: an observational study. Ann Intern Med 2017;166:621-7.
25. Mader JK, Neubauer KM, Schaupp L, et al. Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients. Diabetes Obes Metab 2014; 16: 137-46.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
27. Rochon PA, Katz JN, Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability: a prospective comparison of three comor-bidity indices. Med Care 1996; 34: 1093-101.
28. Umpierrez GE, Reyes D, Smiley D, et al. Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care 2014;37:2934-9.
29. Shepperd S, Lannin NA, Clemson LM, McCluskey A, Cameron ID, Barras SL. Discharge planning from hospital to home. Cochrane Database Syst Rev 2013; 1: CD000313.